T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
54 hedge funds and large institutions have $2.84M invested in T2 Biosystems, Inc in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 11 closing their positions.
175% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 4
133% more call options, than puts
Call options by funds: $21K | Put options by funds: $9K
7% less funds holding
Funds holding: 58 → 54 (-4)
9% less capital invested
Capital invested by funds: $3.12M → $2.84M (-$278K)
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
+$374K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$257K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$84.8K |
| 4 |
Bank of New York Mellon
New York
|
+$57.9K |
| 5 |
Morgan Stanley
New York
|
+$40.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$73K |
| 2 |
VF
Virtu Financial
New York
|
-$52K |
| 3 |
Franklin Resources
San Mateo,
California
|
-$41K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$15K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$13.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RWP
51
Ridgecrest Wealth Partners
Mill Valley,
California
| $1K | – | – | – |
|
52
Wolverine Trading
Chicago,
Illinois
| $1K | +$1.31K | +2 | New |
|
|
TWC
53
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $270 | – | – | – |
|
|
KFS
54
Kelly Financial Services
Braintree,
Massachusetts
| $180 | – | – | – |
|
|
55
Millennium Management
New York
| – | -$73K | -91 | Closed |
|
|
VF
56
Virtu Financial
New York
| – | -$52K | -65 | Closed |
|
|
57
Franklin Resources
San Mateo,
California
| – | -$41K | -51 | Closed |
|
|
TRCT
58
Tower Research Capital (TRC)
New York
| – | -$15K | -18 | Closed |
|
59
HighTower Advisors
Chicago,
Illinois
| – | -$9K | -12 | Closed |
|
60
Victory Capital Management
San Antonio,
Texas
| – | -$4K | -5 | Closed |
|
|
IF
61
Ironwood Financial
Tucson,
Arizona
| – | -$4K | -4 | Closed |
|
|
CL
62
CIM LLC
Albany,
New York
| – | -$3K | -3 | Closed |
|
|
EWM
63
Empirical Wealth Management
Seattle,
Washington
| – | -$2K | -2 | Closed |
|
|
HR
64
Howe & Rusling
Rochester,
New York
| – | -$1K | -1 | Closed |
|
TTOO Hedge Fund Activity: Q3 2022 in Review
54 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q3 2022, worth a combined $2.84M — down 8.9% from $3.12M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of TTOO and 7 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 11 added.
The largest buyer was Altium Capital Management, opening a new position worth an estimated $374K. The largest seller was Millennium Management, exiting entirely with an estimated $73K sold.
- 54 institutional investors held T2 Biosystems, Inc (TTOO) as of Q3 2022, down from 58 in Q2 2022.
- Funds reported $2.84M of T2 Biosystems, Inc stock for Q3 2022, down 8.9% quarter-over-quarter.
- 7 funds opened new T2 Biosystems, Inc positions in Q3 2022 and 11 closed out, a net change of -4 holders.
- The largest T2 Biosystems, Inc buyer in Q3 2022 was Altium Capital Management, an estimated $374K added.
- The largest T2 Biosystems, Inc seller in Q3 2022 was Millennium Management, an estimated $73K sold.
Based on aggregated 13F filings for Q3 2022.